A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease

Clinical trial NCT06566170 · RECRUITING

Trial details

NCT number: NCT06566170
Sponsor: Eli Lilly and Company
Status: RECRUITING
Study type: OBSERVATIONAL

Alzheimer Disease

Start date: 2024-10-07
Primary completion: 2033-02-01
Enrollment: 6250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.